Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes

被引:13
作者
Xie, Yilian [1 ,2 ]
Kong, Weiliang [3 ]
Wang, Xuepeng [1 ,2 ]
Wu, Zhouxiao [1 ,2 ,4 ]
机构
[1] Ningbo First Hosp, Dept Infect Dis, Ningbo 315010, Zhejiang, Peoples R China
[2] Ningbo First Hosp, Dept Hepatol, Ningbo 315010, Zhejiang, Peoples R China
[3] Ningbo First Hosp, Dept Resp & Crit Care Med, Ningbo 315010, Zhejiang, Peoples R China
[4] Ningbo Univ, Sch Med, Ningbo, Zhejiang, Peoples R China
关键词
HbA1c; NAFLD; NHANES; Steatosis; Transient elastography; INSULIN-RESISTANCE; AMERICAN ASSOCIATION; HBA(1C); RISK;
D O I
10.1186/s12902-022-01134-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Type 2 diabetes mellitus (T2DM) is a well-known independent risk factor for non-alcoholic fatty liver disease (NAFLD). However, research exploring the association between blood glucose management and the risk of NAFLD status in subjects without diabetes was insufficient. This study aimed to explore the association of glycated hemoglobin (HbA1c) with NAFLD status and the severity of liver steatosis and fibrosis in non-diabetic people. Methods A cross-sectional analysis was conducted on 2998 non-diabetic American adults using data from the National Health and Nutrition Examination Survey (NHANES) 2017-2018 cycle. We used multivariable logistic regression models to evaluate the association between HbA1c and NAFLD status and the severity of liver steatosis and fibrosis. Interaction and stratified analyses were additionally performed. Results The multivariate regression analyses showed that HbA1c was associated independently with NAFLD status in all the models (model1: OR = 2.834, 95%CI: 2.321, 3.461; model 2: OR = 2.900, 95%CI: 2.312, 3.637 and model 3: OR = 1.664, 95%CI: 1.284, 2.156). We further performed the interaction and stratified analyses and discovered a significant interaction between HbA1c and BMI (P-interaction < 0.05). Finally, a robust link was shown between HbA1c level and the severity of liver steatosis, which was mainly significant in the prediabetes group, while the correlation was not significant in HbA1c level and severity of liver fibrosis after controlling for all the potential confounders. Conclusions We concluded that HbA1c level was positively correlated to the risk of developing NAFLD in a large non-diabetic American population. Moreover, HbA1c level was associated with the severity of liver steatosis in subjects with prediabetes, suggesting that routine screening for HbA1c among individuals with prediabetes is necessary.
引用
收藏
页数:10
相关论文
共 42 条
[1]   Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease [J].
Alexopoulos, Anastasia-Stefania ;
Crowley, Matthew J. ;
Wang, Ying ;
Moylan, Cynthia A. ;
Guy, Cynthia D. ;
Henao, Ricardo ;
Piercy, Dawn L. ;
Seymour, Keri A. ;
Sudan, Ranjan ;
Portenier, Dana D. ;
Diehl, Anna Mae ;
Coviello, Andrea D. ;
Abdelmalek, Manal F. .
HEPATOLOGY, 2021, 74 (03) :1220-1233
[2]  
American A., 2021, DIABETES CARE, V44, pS4 S6
[3]   Classification and Diagnosis of Diabetes [J].
不详 .
DIABETES CARE, 2015, 38 :S8-S16
[4]   A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease [J].
Aykut, Umut Emre ;
Akyuz, Umit ;
Yesil, Atakan ;
Eren, Fatih ;
Gerin, Fatma ;
Ergelen, Rabia ;
Celikel, Cigdem Ataizi ;
Yilmaz, Yusuf .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (11) :1343-1348
[5]   Impact of Nonalcoholic Fatty Liver Disease on Insulin Resistance in Relation to HbA1c Levels in Nondiabetic Subjects [J].
Bae, Ji Cheol ;
Cho, Yong Kyun ;
Lee, Won Young ;
Seo, Hyun Il ;
Rhee, Eun Jung ;
Park, Se Eun ;
Park, Cheol Young ;
Oh, Ki Won ;
Sung, Ki Chul ;
Kim, Byung Ik .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (11) :2389-2395
[6]   Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review [J].
Cariou, Bertrand ;
Byrne, Christopher D. ;
Loomba, Rohit ;
Sanyal, Arun J. .
DIABETES OBESITY & METABOLISM, 2021, 23 (05) :1069-1083
[7]   Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease [J].
Castera, Laurent ;
Friedrich-Rust, Mireen ;
Loomba, Rohit .
GASTROENTEROLOGY, 2019, 156 (05) :1264-+
[8]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[9]   HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels [J].
Chen, Changxi ;
Zhu, Zhongwei ;
Mao, Yushan ;
Xu, Yimin ;
Du, Juan ;
Tang, Xiaoping ;
Cao, Hongbao .
BIOSCIENCE REPORTS, 2020, 40
[10]   Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis [J].
Ciardullo, Stefano ;
Grassi, Guido ;
Mancia, Giuseppe ;
Perseghin, Gianluca .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (04) :365-371